Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

BACKGROUND: Antiangiogenesis is a promising therapy for advanced hepatocellular carcinoma (HCC), but the effects are difficult to be evaluated. Pazopanib (GW786034B) is a pan-vascular endothelial growth factor receptor inhibitor, the antitumor effects or antiangiogenic effects haven't been inve...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Zhu, Xiao-Dong, Zhang, Ju-Bo, Fan, Pei-Li, Xiong, Yu-Quan, Zhuang, Peng-Yuan, Zhang, Wei, Xu, Hua-Xiang, Gao, Dong-Mei, Kong, Ling-Qun, Wang, Lu, Wu, Wei-Zhong, Tang, Zhao-You, Ding, Hong, Sun, Hui-Chuan
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2011
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3033852/
https://ncbi.nlm.nih.gov/pubmed/21251271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-28
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы